136 related articles for article (PubMed ID: 17570122)
1. More on the treatment-tropism relationship: the impact of prior antiretroviral treatment on HIV coreceptor tropism among subjects entering AIDS clinical trials group 175.
Shulman NS; Kassaye SG; Winters MA; Johnston E; Katzenstein DA
J Infect Dis; 2007 Jul; 196(2):328-9; author reply 329-30. PubMed ID: 17570122
[No Abstract] [Full Text] [Related]
2. HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.
Wilkin TJ; Su Z; Kuritzkes DR; Hughes M; Flexner C; Gross R; Coakley E; Greaves W; Godfrey C; Skolnik PR; Timpone J; Rodriguez B; Gulick RM
Clin Infect Dis; 2007 Feb; 44(4):591-5. PubMed ID: 17243065
[TBL] [Abstract][Full Text] [Related]
3. Stable coreceptor usage of HIV in patients with ongoing treatment failure on HAART.
Lehmann C; Däumer M; Boussaad I; Sing T; Beerenwinkel N; Lengauer T; Schmeisser N; Wyen C; Fätkenheuer G; Kaiser R
J Clin Virol; 2006 Dec; 37(4):300-4. PubMed ID: 17005445
[TBL] [Abstract][Full Text] [Related]
4. HIV biological variability unveiled: frequent isolations and chimeric receptors reveal unprecedented variation of coreceptor use.
Karlsson I; Antonsson L; Shi Y; Karlsson A; Albert J; Leitner T; Olde B; Owman C; Fenyö EM
AIDS; 2003 Dec; 17(18):2561-9. PubMed ID: 14685050
[TBL] [Abstract][Full Text] [Related]
5. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
Waters L; Mandalia S; Randell P; Wildfire A; Gazzard B; Moyle G
Clin Infect Dis; 2008 May; 46(10):1617-23. PubMed ID: 18419499
[TBL] [Abstract][Full Text] [Related]
6. [Anti-HIV therapy (1987-1994): from nothing to confusion].
Lissen E
Med Clin (Barc); 1995 Apr; 104(12):463-7. PubMed ID: 7739285
[No Abstract] [Full Text] [Related]
7. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
[TBL] [Abstract][Full Text] [Related]
8. HIV coreceptor phenotyping in the clinical setting.
Low AJ; Swenson LC; Harrigan PR
AIDS Rev; 2008; 10(3):143-51. PubMed ID: 18820716
[TBL] [Abstract][Full Text] [Related]
9. Combined drugs may be better than zidovudine alone for immunocompromised adults infected with HIV-1.
Commun Dis Rep CDR Wkly; 1995 Oct; 5(42):209. PubMed ID: 7496435
[No Abstract] [Full Text] [Related]
10. HIV-1 tropism, disease progression, and clinical management.
Burger H; Hoover D
J Infect Dis; 2008 Oct; 198(8):1095-7. PubMed ID: 18783314
[No Abstract] [Full Text] [Related]
11. [Combination therapies with anti-retroviral agents in HIV and AIDS infections].
Fernández-Cruz E
Rev Clin Esp; 1991 Oct; 189(6):253-5. PubMed ID: 1722345
[No Abstract] [Full Text] [Related]
12. HIV type 1 tropism and inhibitors of viral entry: clinical implications.
Weber J; Piontkivska H; Quiñones-Mateu ME
AIDS Rev; 2006; 8(2):60-77. PubMed ID: 16848274
[TBL] [Abstract][Full Text] [Related]
13. A bend in the road--implications of ACTG 175 and Delta trials.
Hirsch MS; Yeni P
Antivir Ther; 1996 Jan; 1(1):6-8. PubMed ID: 11322260
[No Abstract] [Full Text] [Related]
14. Anti-HIV therapy lowers risk of AIDS, death in patients with intermediate-stage HIV disease.
AIDS Patient Care; 1995 Dec; 9(6):303. PubMed ID: 11361440
[No Abstract] [Full Text] [Related]
15. HIV-1 X4/R5 co-receptor in viral reservoir during suppressive HAART.
Soulié C; Marcelin AG; Ghosn J; Amellal B; Assoumou L; Lambert S; Duvivier C; Costagliola D; Katlama C; Calvez V
AIDS; 2007 Oct; 21(16):2243-5. PubMed ID: 18090053
[TBL] [Abstract][Full Text] [Related]
16. Managing HIV. Part 4: Primary therapy. 4.1 Antiretroviral therapies for HIV.
Crowe S; Cooper DA; Chambers DE
Med J Aust; 1996 Mar; 164(5):290-5. PubMed ID: 8628165
[TBL] [Abstract][Full Text] [Related]
17. The epidemiology of HIV coreceptor tropism.
Hoffmann C
Eur J Med Res; 2007 Oct; 12(9):385-90. PubMed ID: 17933718
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes.
Garrido C; Roulet V; Chueca N; Poveda E; Aguilera A; Skrabal K; Zahonero N; Carlos S; García F; Faudon JL; Soriano V; de Mendoza C
J Clin Microbiol; 2008 Mar; 46(3):887-91. PubMed ID: 18199789
[TBL] [Abstract][Full Text] [Related]
19. [Anti-retroviral treatment. Approach to previously treated patients].
Antela A; Podzamczer D; Ruiz I; Parras F
Enferm Infecc Microbiol Clin; 1996 Oct; 14 Suppl 1():24-30. PubMed ID: 9053023
[No Abstract] [Full Text] [Related]
20. [Antiretroviral treatment against HIV].
González-Lahoz J; Soriano V
Med Clin (Barc); 1995 Sep; 105(10):377-8. PubMed ID: 7475441
[No Abstract] [Full Text] [Related]
[Next] [New Search]
